Immunogen, Inc.

Immunogen, Inc.

IMGN

Market Cap$0
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Immunogen, Inc.Immunogen, Inc.00%-31.2-
$33.47

Current Fair Value

7.1% upside

Undervalued by 7.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$0.00
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.28
Beta0.0
Outstanding Shares266,264,274
Avg 30 Day Volume0

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-0.0
Price to Sales31.24
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Immunogen, Inc.

CEO: Mark Enyedy